Amgen, Pfizer Settle Patent Suit on Biosimilar of Neupogen Drug – Bloomberg Law

Amgen had claimed that a biosimilar version of Neupogen by Pfizer ‘s Hospira unit infringed a patent for the cancer drug. No details provided in stipulation and …